KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Equity Average (2019 - 2025)

GoodRx Holdings' Equity Average history spans 7 years, with the latest figure at $608.5 million for Q4 2025.

  • For Q4 2025, Equity Average fell 14.36% year-over-year to $608.5 million; the TTM value through Dec 2025 reached $608.5 million, down 14.36%, while the annual FY2025 figure was $670.5 million, 9.8% down from the prior year.
  • Equity Average for Q4 2025 was $608.5 million at GoodRx Holdings, down from $621.9 million in the prior quarter.
  • Across five years, Equity Average topped out at $888.3 million in Q3 2023 and bottomed at $608.5 million in Q4 2025.
  • The 5-year median for Equity Average is $794.2 million (2021), against an average of $755.4 million.
  • The largest annual shift saw Equity Average soared 718.06% in 2021 before it dropped 24.52% in 2024.
  • A 5-year view of Equity Average shows it stood at $839.0 million in 2021, then fell by 4.46% to $801.6 million in 2022, then rose by 2.5% to $821.6 million in 2023, then decreased by 13.52% to $710.5 million in 2024, then fell by 14.36% to $608.5 million in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Equity Average are $608.5 million (Q4 2025), $621.9 million (Q3 2025), and $648.7 million (Q2 2025).